Full Text View
Tabular View
No Study Results Posted
Related Studies
Macugen for Histoplasmosis
This study has been terminated.
Study NCT00272766   Information provided by Barnes Retina Institute

First Received on January 4, 2006.   Last Updated on October 25, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ocular Histoplasmosis
Choroidal Neovascularization
Additional conditions recognized in this trial
Histoplasmosis
Neovascularization, Pathologic
More general conditions related to this trial
Choroid Diseases
Eye Diseases
Metaplasia
Mycoses
Pathologic Processes
Uveal Diseases
Interventions listed in this trial
pegaptanib sodium
Sponsors listed in this trial
Barnes Retina Institute
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services